Ulrikka Nygaard: Clinical Trials

2 trials sponsored by Ulrikka Nygaard, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow Ulrikka Nygaard: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Switch in Pediatric Bloodstream Infections
Oral antibiotic therapy, Standard IV antibiotic therapy - Bloodstream Infection, Bacteremia Sepsis
Phase 4RecruitingUlrikka Nygaard1502026-09-012026-10-19
Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns.
Individualized treatment duration strategy - Early-Onset Neonatal Sepsis, Antibiotic Side Effect
Phase 4CompletedUlrikka Nygaard4882022-04-222026-01-12

Conditions studied

Bacteremia (1)  ·  Infections (1)  ·  Neonatal Sepsis (1)  ·  Sepsis (1)

Interventions

Anti-Infective Agents (1)

Countries

Denmark (2)

Top investigators

Emma Malchau Carlsen, MD, PhD (1)  ·  Tine Brink Henriksen, MD, Prof (1)

Results publications

PMID 42302804